This digital series features articles and videos with insights and expert viewpoints on PSMA-PET and the evolving imaging paradigm that is revolutionizing the diagnosis and treatment of patients with prostate cancer.
EP. 1: Harnessing the Full Power of PSMA-PET Requires Multidisciplinary Approach
PSMA-PET imaging has successfully disrupted the prostate cancer paradigm and experts agree that unleashing the full potential of this breakthrough requires a multidisciplinary approach.
EP. 2: Dr. Spratt on the importance of a multidisciplinary approach to PSMA-PET
“I think that having the clinical context such as the PSA, the Gleason score, the other features that assess the aggressiveness of the disease can really help with some of these subtle findings that can be found on PET imaging,” says Daniel Spratt, MD.
EP. 3: PSMA-PET leads imaging breakthroughs in prostate cancer paradigm
Daniel Spratt, MD, highlights the evolving paradigm of PET-based imaging agents in prostate cancer, with a focus on the impact of PSMA-PET imaging.
2 Commerce Drive Cranbury, NJ 08512